We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
+1.53%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$64.8B
AUM Growth
-$1.23B
Cap. Flow
+$395M
Cap. Flow %
0.61%
Top 10 Hldgs %
28.4%
Holding
1,116
New
212
Increased
277
Reduced
389
Closed
160

Top Buys

Rank Stock Value
1
RVMD icon
Revolution Medicines
RVMD
+$330M
2
CTRA
Coterra Energy
CTRA
+$214M
3
BSX icon
Boston Scientific
BSX
+$204M
4
RBA icon
RB Global
RBA
+$183M
5
CVX icon
Chevron
CVX
+$131M

Top Sells

Rank Stock Value
1
RNAM
Avidity Biosciences
RNAM
+$190M
2
RPRX icon
Royalty Pharma
RPRX
+$187M
3
DOV icon
Dover
DOV
+$178M
4
BA icon
Boeing
BA
+$168M
5
DVN icon
Devon Energy
DVN
+$155M

Sector Composition

Rank Sector Weight
1 Technology 27.24%
2 Healthcare 15.45%
3 Financials 12.46%
4 Industrials 9.23%
5 Communication Services 8.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PNW icon
326
Pinnacle West Capital
PNW
$12.9B
$34.9M 0.05%
346,783
+181,797
+110% +$17.5M
MSCI icon
327
MSCI
MSCI
$40B
$34.9M 0.05%
64,800
+5,000
+8% +$2.82M
COIN icon
328
Coinbase
COIN
$41.7B
$34.9M 0.05%
199,800
-6,200
-3% -$1.22M
CVNA icon
329
Carvana
CVNA
$43.3B
$34.8M 0.05%
553,500
-85,000
-13% -$6.31M
NUE icon
330
Nucor
NUE
$56.4B
$34.7M 0.05%
205,000
-1,600
-0.8% -$279K
DELL icon
331
Dell
DELL
$283B
$34.7M 0.05%
211,200
-900
-0.4% -$120K
MIRM icon
332
Mirum Pharmaceuticals
MIRM
$6.89B
$34.6M 0.05%
375,000
-92,468
-20% -$8.7M
MGTX icon
333
MeiraGTx Holdings
MGTX
$1.09B
$34.6M 0.05%
4,000,000
– –
ELAN icon
334
Elanco Animal Health
ELAN
$12.4B
$34.5M 0.05%
1,443,688
+628,363
+77% +$15.4M
HAS icon
335
Hasbro
HAS
$12.6B
$34.5M 0.05%
368,972
-54,400
-13% -$5.08M
SRRK icon
336
Scholar Rock
SRRK
$5.71B
$34.4M 0.05%
+700,000
New +$31.4M
ALL icon
337
Allstate
ALL
$66.9B
$34.4M 0.05%
165,919
-300
-0.2% -$61.5K
NDAQ icon
338
Nasdaq
NDAQ
$51.5B
$34.2M 0.05%
403,047
-190,900
-32% -$17.1M
AN icon
339
AutoNation
AN
$6.97B
$34.2M 0.05%
175,000
+142,000
+430% +$28.7M
GRMN
340
Garmin
GRMN
$46.9B
$34M 0.05%
146,470
-1,100
-0.7% -$246K
ERAS icon
341
Erasca
ERAS
$6.63B
$34M 0.05%
+2,100,000
New +$24.8M
JCAP
342
Jefferson Capital
JCAP
$1.22B
$33.9M 0.05%
1,762,799
+475,290
+37% +$10.1M
ROP icon
343
Roper Technologies
ROP
$36.3B
$33.8M 0.05%
95,501
-27,830
-23% -$10.3M
QRVO icon
344
Qorvo
QRVO
$7.63B
$33.6M 0.05%
434,311
+159,311
+58% +$12.9M
RSG icon
345
Republic Services
RSG
$66.7B
$33.6M 0.05%
+153,316
New +$33.6M
RLMD icon
346
Relmada Therapeutics
RLMD
$544M
$33.2M 0.05%
4,763,158
+493,158
+12% +$2.33M
EQR icon
347
Equity Residential
EQR
$25.4B
$33M 0.05%
558,129
+139,614
+33% +$8.61M
AMAL icon
348
Amalgamated Financial
AMAL
$1.48B
$32.7M 0.05%
840,108
-113,751
-12% -$4.31M
AURA icon
349
Aura Biosciences
AURA
$729M
$32.7M 0.05%
4,881,125
– –
UNH icon
350
PUT
UnitedHealth
UNH
$382B
$32.5M 0.05%
+120,000
New +$35.7M
12 13
14
15 16

Similar funds

Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $64B AUM 22.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Caisse de Depot et Placement du Quebec (CDPQ)
Caisse de Depot et Placement du Quebec (CDPQ) Montreal, Quebec, Canada $62.4B AUM 23.7% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $67.5B AUM 28.09% 1-Year Est. Return

Adage Capital Partners's Q1 2026 Portfolio in Review

As of Q1 2026, Adage Capital Partners held 1,116 positions worth $64.8B, down 1.9% from $66.1B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Adage Capital Partners's Q1 2026 filing shows 212 new, 277 increased, 389 reduced and 160 closed positions. Its largest new stake was Takeda Pharmaceutical: 6,424,984 shares worth $119M. The largest sale was Avidity Biosciences, an estimated $190M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.

  • Adage Capital Partners's largest Q1 2026 buy was Takeda Pharmaceutical: 6,424,984 shares worth $119M.
  • Adage Capital Partners added most to Revolution Medicines in Q1 2026, an estimated $330M increase.
  • Adage Capital Partners's biggest Q1 2026 reduction was Royalty Pharma, cutting an estimated $187M.
  • Adage Capital Partners fully exited Avidity Biosciences in Q1 2026, selling an estimated $190M.
  • Adage Capital Partners's ten largest holdings make up 28% of its $64.8B portfolio in Q1 2026.
  • Adage Capital Partners opened 212 new positions and closed 160 in Q1 2026.
  • Adage Capital Partners's portfolio value fell 1.9% quarter-over-quarter to $64.8B.

Based on Adage Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.